Severe Asthma Patients Experience and Satisfaction with Virtual Clinics during COVID-19 Period

Background Enforced social distancing (i.e., lockdowns) greatly facilitated control of coronavirus disease-19 (COVID-19). While access to hospitals was restricted, outpatient care continued remotely. The aim of this study was to determine the satisfaction of patients with severe asthma with telemedi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Mohammad Ayaz Khan, Rajendram Rajkumar, Mohammad Hammadi, Majed Al-Gamedi, Abdullah Al-Harbi, Hamdan Al-Jahdali
Formato:	article
Lenguaje:	EN
Publicado:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2021
Materias:	asthma biological therapy covid-19 sars-cov-2 outpatient Medicine R
Acceso en línea:	https://doaj.org/article/d8bb87a2c3a742989f23f16174c174eb
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:d8bb87a2c3a742989f23f16174c174eb
record_format	dspace
spelling	oai:doaj.org-article:d8bb87a2c3a742989f23f16174c174eb2021-12-02T18:32:47ZSevere Asthma Patients Experience and Satisfaction with Virtual Clinics during COVID-19 Period2231-07702249-446410.1055/s-0041-1732283https://doaj.org/article/d8bb87a2c3a742989f23f16174c174eb2021-08-01T00:00:00Zhttp://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1732283https://doaj.org/toc/2231-0770https://doaj.org/toc/2249-4464Background Enforced social distancing (i.e., lockdowns) greatly facilitated control of coronavirus disease-19 (COVID-19). While access to hospitals was restricted, outpatient care continued remotely. The aim of this study was to determine the satisfaction of patients with severe asthma with telemedicine, and the impact of COVID-19 lockdown on severe asthma patients on biologics therapy. Methods A cross-sectional survey of patients with severe asthma scheduled to receive biologic therapy at our hospital during the lockdown. The survey had sections about demographic data, asthma history, subjective perception of change in asthma control with biologic agent, the effect of COVID-19 pandemic on access to maintenance therapy for asthma, asthma exacerbation management, and satisfaction with telephone follow-up. Results Fifty-four patients participated (response rate 93.1%; male 17; mean age 46.7 years). All had been on biologic therapy for over 3 months (mean 38.4 months ± standard deviation 26.5 months). Of the 45 patients living in Riyadh, 9 did not receive biologic therapy. Five of the nine patients living outside Riyadh did not receive biologic therapy. Alarmingly, 16 (29.6%) had insufficient medications, and 27 (50%) had difficulty obtaining medications. Fifty (92.6%) had telephone follow-up, 31 (57.4%) were satisfied with telemedicine. Conclusion Many patients were satisfied with telemedicine, so this could be used to deliver routine outpatient tertiary care postpandemic. However, logistics around supplying medications and biologics must be considered in plans preparing for the second wave of COVID-19.Mohammad Ayaz KhanRajendram RajkumarMohammad HammadiMajed Al-GamediAbdullah Al-HarbiHamdan Al-JahdaliThieme Medical and Scientific Publishers Pvt. Ltd.articleasthmabiological therapycovid-19sars-cov-2outpatientMedicineRENAvicenna Journal of Medicine, Vol 11, Iss 03, Pp 126-131 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	asthma biological therapy covid-19 sars-cov-2 outpatient Medicine R
spellingShingle	asthma biological therapy covid-19 sars-cov-2 outpatient Medicine R Mohammad Ayaz Khan Rajendram Rajkumar Mohammad Hammadi Majed Al-Gamedi Abdullah Al-Harbi Hamdan Al-Jahdali Severe Asthma Patients Experience and Satisfaction with Virtual Clinics during COVID-19 Period
description	Background Enforced social distancing (i.e., lockdowns) greatly facilitated control of coronavirus disease-19 (COVID-19). While access to hospitals was restricted, outpatient care continued remotely. The aim of this study was to determine the satisfaction of patients with severe asthma with telemedicine, and the impact of COVID-19 lockdown on severe asthma patients on biologics therapy. Methods A cross-sectional survey of patients with severe asthma scheduled to receive biologic therapy at our hospital during the lockdown. The survey had sections about demographic data, asthma history, subjective perception of change in asthma control with biologic agent, the effect of COVID-19 pandemic on access to maintenance therapy for asthma, asthma exacerbation management, and satisfaction with telephone follow-up. Results Fifty-four patients participated (response rate 93.1%; male 17; mean age 46.7 years). All had been on biologic therapy for over 3 months (mean 38.4 months ± standard deviation 26.5 months). Of the 45 patients living in Riyadh, 9 did not receive biologic therapy. Five of the nine patients living outside Riyadh did not receive biologic therapy. Alarmingly, 16 (29.6%) had insufficient medications, and 27 (50%) had difficulty obtaining medications. Fifty (92.6%) had telephone follow-up, 31 (57.4%) were satisfied with telemedicine. Conclusion Many patients were satisfied with telemedicine, so this could be used to deliver routine outpatient tertiary care postpandemic. However, logistics around supplying medications and biologics must be considered in plans preparing for the second wave of COVID-19.
format	article
author	Mohammad Ayaz Khan Rajendram Rajkumar Mohammad Hammadi Majed Al-Gamedi Abdullah Al-Harbi Hamdan Al-Jahdali
author_facet	Mohammad Ayaz Khan Rajendram Rajkumar Mohammad Hammadi Majed Al-Gamedi Abdullah Al-Harbi Hamdan Al-Jahdali
author_sort	Mohammad Ayaz Khan
title	Severe Asthma Patients Experience and Satisfaction with Virtual Clinics during COVID-19 Period
title_short	Severe Asthma Patients Experience and Satisfaction with Virtual Clinics during COVID-19 Period
title_full	Severe Asthma Patients Experience and Satisfaction with Virtual Clinics during COVID-19 Period
title_fullStr	Severe Asthma Patients Experience and Satisfaction with Virtual Clinics during COVID-19 Period
title_full_unstemmed	Severe Asthma Patients Experience and Satisfaction with Virtual Clinics during COVID-19 Period
title_sort	severe asthma patients experience and satisfaction with virtual clinics during covid-19 period
publisher	Thieme Medical and Scientific Publishers Pvt. Ltd.
publishDate	2021
url	https://doaj.org/article/d8bb87a2c3a742989f23f16174c174eb
work_keys_str_mv	AT mohammadayazkhan severeasthmapatientsexperienceandsatisfactionwithvirtualclinicsduringcovid19period AT rajendramrajkumar severeasthmapatientsexperienceandsatisfactionwithvirtualclinicsduringcovid19period AT mohammadhammadi severeasthmapatientsexperienceandsatisfactionwithvirtualclinicsduringcovid19period AT majedalgamedi severeasthmapatientsexperienceandsatisfactionwithvirtualclinicsduringcovid19period AT abdullahalharbi severeasthmapatientsexperienceandsatisfactionwithvirtualclinicsduringcovid19period AT hamdanaljahdali severeasthmapatientsexperienceandsatisfactionwithvirtualclinicsduringcovid19period
_version_	1718377949604872192

Severe Asthma Patients Experience and Satisfaction with Virtual Clinics during COVID-19 Period

Ejemplares similares